J&J E-mails Link Research Center, Risperdal

Law360, New York (November 25, 2008, 12:00 AM EST) -- E-mail messages released as part of a lawsuit over Johnson & Johnson's anti-psychotic Risperdal have revealed that the drugmaker worked with a renowned psychiatrist to launch a research center, allegedly for the purpose of marketing the drug for use in children before that use was approved.

The internal e-mails — from J&J subsidiary Janssen Pharmaceutica employees — concern Massachusetts General Hospital physician Joseph Biederman, who has come under fire recently for his drug company ties. The 2002 e-mails reveal the psychiatrist's interest in creating a “Janssen/...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.